A phase 1/2 study of the TORC1/2 inhibitor onatasertib combined with toripalimab in patients with advanced solid tumors: Cervical cancer cohort

被引：0
作者：
Yuan, Li
Shu, Pei
Li, Xiaoyu
Li, Guiling
Zhang, Keqiang
Lai, Lin
Hong, Jinsheng
Huang, Chu-Ying
Wang, Yongsheng
Xie, Hui
Zheng, Li
Zhou, Qi
机构：
[1] Chongqing Univ Canc Hosp, Chongqing, Peoples R China
[2] Sichuan Univ, West China Hosp, Natl Med Prod Adm Key Lab Clin Res & Evaluat Inno, Clin Trial Ctr,State Key Lab Biotherapy, Chengdu, Peoples R China
[3] Huazhong Univ Sci & Technol, Union Hosp, Tongji Med Coll, Wuhan, Peoples R China
[4] Hunan Canc Hosp, Changsha, Peoples R China
[5] Cent Hosp Enshi Tujia & Miao Autonomous Prefectur, Dept Abdominal Oncol, Enshi, Peoples R China
[6] Fujian Med Univ, Dept Radiotherapy, Ctr Canc, Affiliated Hosp 1, Fuzhou, Peoples R China
[7] Hubei Selenium & Human Hlth Inst, Cent Hosp Enshi Tujia & Miao Autonomous Prefectur, Enshi, Peoples R China
[8] Sichuan Univ, West China Hosp, Chengdu, Peoples R China
[9] Antengene Corp, Dept Clin Res & Dev, Shanghai, Peoples R China
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2024年 / 42卷 / 16期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
5509
引用
收藏
页数：1
相关论文
共 50 条
[21]   Phase I expansion trial of an oral TORC1/TORC2 inhibitor (CC-223) in nonpancreatic neuroendocrine tumors (NET). [J].
Mita, Monica M. ;
Wolin, Edward M. ;
Meyer, Tim ;
Nemunaitis, John J. ;
Bergsland, Emily K. ;
Mahipal, Amit ;
Wong, Lilly ;
Wu, Xiaoling ;
Carmichael, James ;
Chopra, Rajesh ;
Hege, Kristen ;
Bendell, Johanna C. .
JOURNAL OF CLINICAL ONCOLOGY, 2013, 31 (15)
[22]   Palomid 529, a Combined TORC1/TORC2 Inhibitor, Suppresses Spasms in a Rat Model of Infantile Spasms [J].
Galanopoulou, Aristea S. ;
Sherris, David .
ANNALS OF NEUROLOGY, 2010, 68 (04) :S39-S39
[23]   A phase I dose-escalation study of the safety, pharmacokinetics (PK), and pharmacodynamics of XL765, a PI3K/TORC1/TORC2 inhibitor administered orally to patients (pts) with advanced solid tumors [J].
LoRusso, P. ;
Markman, B. ;
Tabernero, J. ;
Shazer, R. ;
Nguyen, L. ;
Heath, E. ;
Patnaik, A. ;
Papadopoulos, K. .
JOURNAL OF CLINICAL ONCOLOGY, 2009, 27 (15)
[24]   A phase 1 study of gemcitabine combined with dasatinib in patients with advanced solid tumors [J].
Hong, David S. ;
Choe, Jennifer Hsing ;
Naing, Aung ;
Wheler, Jennifer J. ;
Falchook, Gerald S. ;
Piha-Paul, Sarina ;
Moulder, Stacy L. ;
George, Goldy C. ;
Choe, Jonathan M. ;
Strauss, Lewis C. ;
Gallick, Gary E. ;
Kurzrock, Razelle .
INVESTIGATIONAL NEW DRUGS, 2013, 31 (04) :918-926
[25]   A phase 1 study of gemcitabine combined with dasatinib in patients with advanced solid tumors [J].
David S. Hong ;
Jennifer Hsing Choe ;
Aung Naing ;
Jennifer J. Wheler ;
Gerald S. Falchook ;
Sarina Piha-Paul ;
Stacy L. Moulder ;
Goldy C. George ;
Jonathan M. Choe ;
Lewis C. Strauss ;
Gary E. Gallick ;
Razelle Kurzrock .
Investigational New Drugs, 2013, 31 :918-926
[26]   Phase 1/2a Study of Rivoceranib, a Selective VEGFR-2 Angiogenesis Inhibitor, in Patients with Advanced Solid Tumors [J].
Kang, Yoon-Koo ;
Ryu, Min -Hee ;
Hong, Yong Sang ;
Choi, Chang-Min ;
Kim, Tae Won ;
Ryoo, Baek-Yeol ;
Kim, Jeong Eun ;
Weis, John R. ;
Kingsford, Rachel ;
Park, Cheol Hee ;
Jang, Seong ;
Mcginn, Arlo ;
Werner, Theresa L. ;
Sharma, Sunil .
CANCER RESEARCH AND TREATMENT, 2024, 56 (03) :743-750
[27]   Phase 1/2 study of monalizumab plus durvalumab in patients with advanced solid tumors [J].
Patel, Sandip P. ;
Alonso-Gordoa, Teresa ;
Banerjee, Susana ;
Wang, Ding ;
Naidoo, Jarushka ;
Standifer, Nathan E. ;
Palmer, Doug C. ;
Cheng, Lin-Yang ;
Kourtesis, Panagiotis ;
Ascierto, Maria L. ;
Das, Mayukh ;
Diamond, Jennifer R. ;
Hellmann, Matthew D. ;
Carneiro, Benedito A. .
JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2024, 12 (02)
[28]   Targeting NFE2L2/KEAP1 Mutations in Advanced NSCLC With the TORC1/2 Inhibitor TAK-228 [J].
Paik, Paul K. ;
Fan, Pang-Dian ;
Qeriqi, Besnik ;
Namakydoust, Azadeh ;
Daly, Bobby ;
Ahn, Linda ;
Kim, Rachel ;
Plodkowski, Andrew ;
Ni, Ai ;
Chang, Jason ;
Fanaroff, Rachel ;
Ladanyi, Marc ;
de Stanchina, Elisa ;
Rudin, Charles M. .
JOURNAL OF THORACIC ONCOLOGY, 2023, 18 (04) :516-526
[29]   Targeting NFE2L2/KEAP1 mutations in advanced NSCLC with the TORC1/2 inhibitor TAK-228. [J].
Paik, Paul K. ;
Ahn, Linda Su Hyun ;
Ginsberg, Michelle S. ;
Plodkowski, Andrew J. ;
Kim, Rachel ;
Doyle, L. Austin ;
Rudin, Charles M. .
JOURNAL OF CLINICAL ONCOLOGY, 2019, 37 (15)
[30]   A Phase 1 study of INCMGA00012, a PD-1 inhibitor, in patients with advanced solid tumors: Preliminary results for patients with advanced cervical cancer (POD1UM-101) [J].
Mehnert, Janice ;
Paz Ares, Luis ;
Pikiel, Joanna ;
Banerji, Udai ;
Kryzhanivska, Anna ;
Lakhani, Nehal ;
Ochsenreiter, Sebastian ;
Arkenau, Tobias ;
Bourayou, Nawel ;
Kornacki, Deanna ;
Tian, Chuan ;
Condamine, Thomas ;
Gardeazabal Gonzalez, Itziar .
JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2019, 7
12345